glp-1 agonist gastroparesis Gastroparesis: Hidden Dangers Beyond C Glucagon-Like Peptide-1 Agonists and General

The condition generally occurs without warning and causes optic nerve damage due to ischemia

In the over 2500 participants, who were assigned to the 5, 10, and 15 mg doses of tirzepatide and placebo, the percent weight changes were both statistically and clinically significant compared with placebo

Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease

Retatrutide simultaneously engages GLP-1, GIP, and glucagon receptors, producing a broader receptor-activation profile

The risk of cardiac arrest is also below 1%

Liraglutide for perioperative management of hyperglycaemia in cardiac surgery patients: a multicentre randomized superiority trial